Tech Company Financing Transactions
Moximed Funding Round
Moximed secured a $50 million Series C investment round on 3/17/2017. Backers included Advent Life Sciences, Future Fund and GBS Venture Partners.
Transaction Overview
Company Name
Announced On
3/17/2017
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Series C
Investors
Proceeds Purpose
This financing round is timely, as we are completing the primary endpoint follow-up for our FDA pivotal study this month," said CEO Kevin Sidow.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
46602 Landing Pkwy.
Fremont, CA 94538
USA
Fremont, CA 94538
USA
Phone
Website
Email Address
Overview
Moximed, Inc. is dedicated to improving the standard of care for patients with osteoarthritis (OA). OA, the most common form of arthritis, leads to a breakdown of the joint's cartilage and often results in joint pain and loss of motion.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 3/17/2017: Akonni Biosystems venture capital transaction
Next: 3/17/2017: Appuri venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs